Vacumed - from the idea to the therapeutic concept
Space technology against leg disorders and vascular diseases Nine out of ten German adults suffer from weakness of the veins. Chronic venous insufficiency (CVI) has a high prevalence. Varicose veins, thromboses, postthrombotic syndrome and other related disorders have become more and more prevalent over time, now affecting a significant portion of the population. Early onset of the named diseases and increasing life expectancy has resulted in a costs explosion.The overall picture is similar for arterial insufficiency: Arteriosclerosis and peripheral arterial occlusive disease (PAOD) are of more than just local importance (smoker's leg, amputation); they mark an increased risk for cardiac and cerebrovascular complications including myocardial infarction and stroke, the no 1 cause of death!
The intermittent negative pressure wave therapy is setting new standards in the treatment of leg disorders. Backed by expert opinions from angiology, phlebology, and lymphology, it leaves a mark in the preventive measures market.
The VACUMED(R) device has its origins in space medicine research. No astronaut engaged in the manned exploration of space can do without the "lower body negative pressure device (LBNPD)". It helps him/her to stay fit in the weightlessness of space and to maintain adequate arterial blood supply of the lower extremities. Numerous tests carried out by NASA and the German Space Agency (DLR) proof the easily measurable capillary dilation and capillarisation, together with an increase in micro- and macro-perfusion in the lower extremities even with continuous negative pressure application.
Learn more about the aims and capabilities of the Vacumed!
